NDC Code Detail Logo

76117-001-16 : NDC 2026 Code

76117-001-16 : Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride ( Rycontuss )

Additionally :
You can get information about “76117-001-16” NDC code in 76117-001-16 in HTML format HTML  |  76117-001-16 in TXT (Plain Text) format TXT  |  76117-001-16 in PDF (Portable Document Format) PDF  |  76117-001-16 in XML format XML  formats.

NDC Code : 76117-001-16 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "76117-001-16",
    "PackageDescription": "473 mL in 1 BOTTLE (76117-001-16) ",
    "NDC11Code": "76117-0001-16",
    "ProductNDC": "76117-001",
    "ProductTypeName": "HUMAN OTC DRUG",
    "ProprietaryName": "Rycontuss",
    "ProprietaryNameSuffix": "Cherry Flavor",
    "NonProprietaryName": "Chlorpheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride",
    "DosageFormName": "LIQUID",
    "RouteName": "ORAL",
    "StartMarketingDate": "20110531",
    "EndMarketingDate": null,
    "MarketingCategoryName": "OTC MONOGRAPH DRUG",
    "ApplicationNumber": "M012",
    "LabelerName": "Okendpharma, Inc.",
    "SubstanceName": "CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE",
    "StrengthNumber": "2; 10; 5",
    "StrengthUnit": "mg/5mL; mg/5mL; mg/5mL",
    "Pharm_Classes": "Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-12-13",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20110531",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}
                
            

Copyright © 2007-2026 Data Labs Health. All rights reserved.